Deucravacitinib onset of action and maintenance of response in phase 3 plaque psoriasis trials

By sjmartinez • July 1, 2024

Korman NJ, Warren RB, Bagel J, Armstrong AW, Gooderham M, Strober B, Thaçi D, Morita A, Imafuku S, Foley P, Sofen H, Zheng M, Hippeli L, Kisa RM, Banerjee S, Blauvelt A. Deucravacitinib onset of action and maintenance of response in phase 3 plaque psoriasis trials. J Dermatolog Treat. 2024 Dec;35(1):2371045. doi: 10.1080/09546634.2024.2371045. Epub 2024 Jun 30. PMID: 38945549.

Tags: clinical trials, Dermatology, deucravacitinib, maintenance of response, onset of action, phase 3, POETYK PSO-1, POETYK PSO-2, psoriasis, Publications

Predatory Conferences and Journals in Dermatology Are Black Widow Parties

Murrell DF, Weinberg JM, Yamauchi PS, Abdelmaksoud A, Grabbe S, Goldust M. Predatory Conferences and Journals in Dermatology Are Black Widow Parties. Skinmed. 2024 Oct[...]

Putative pseudolysogeny-dependent phage gene implicated in the superinfection resistance of Cutibacterium acnes

Wottrich S, Mendonca S, Safarpour C, Nguyen C, Marinelli LJ, Hancock SP, Modlin RL, Parker JM. Putative pseudolysogeny-dependent phage gene implicated in the superinfection resistance[...]

Contact Dermatitis in the United States: A Population-Based Study on Patient Visit Characteristics and Treatment Prescription Patterns

Hao A, Yu RP, Kikuchi R, Sadrolashrafi K, Guo L, Yamamoto RK, Tolson H, Yee D, Bilimoria S, Pourali SP, Adler BL, Armstrong AW. Contact[...]